Receptors, cholecystokinin - Open Access .click

Results 141 to 150 of about 437,706 (248)

Development of Innovative Foldamers for the Peptide Receptor Radionuclide Therapy of Tumours Overexpressing Cholecystokinin-2 Receptors [PDF]

Peptide Receptor Radionuclide Therapy (PRRT) is a systematic treatment used to deliver high levels of radiation to cancer using radiopharmaceuticals known as theranostic agents (TAs). Until now TAs have been limited to only a few cancer types.

core

Targeting Melanocortin and Cholecystokinin Receptors via Multivalent Molecules Bearing Peptide Ligands [PDF]

, 2014
Peptide receptor overexpression in diseased cells and tissues, including carcinomas provides an opportunity to develop therapeutics and imaging agents that selectively bind to such cells and tissues.
Nakath Gamlath Ralalage, Dayan Elshan
core

The physiology of the biliary tree. Motility of the gallbladder - Part 1

The Saudi Journal of Gastroenterology, 1999
An incomplete picture has emerged of the complex means by which gallbladder motility is controlled under normal and pathophysiological conditions. In the first part of this review an overall account is presented. The mechanisms of cholecystokinin release,
Ballal Mansour, Sanford Paul
doaj

Correction: Evaluating the therapeutic efficacy of gastramide theranostics targeting cholecystokinin-2 receptors in a preclinical setting. [PDF]